Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00919412 · ClinicalTrials.gov registry record
Non Invasive Biomarkers to Identify Subjects at Risk for Preterm Delivery
A clinical trial, sponsored by NYU Langone Health.
- Terminated
- Registry status
- 32
- Enrollment target
NCT00919412: Clinical Trial study, sponsored by NYU Langone Health.
NCT00919412 is a clinical trial that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00919412 was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- 32 participants
- Enrollment target
Study Summary
The goal of this study is to identify a non-invasive predictor or predictors that will increase the clinician's ability to identify patients with preterm labor (PTL) at risk for preterm delivery (PTD). Through these studies we also hope to reveal potential therapeutic targets in the prevention of prevention of preterm births. The study hypothesis is that we can identify non-invasive predictors of PTL at risk for PTD.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2007-06 |
| Est. Completion | 2010-09 |
Why NCT00919412 stopped before completion
NCT00919412 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00919412 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00919412 about?
NCT00919412 is a clinical study titled "Non Invasive Biomarkers to Identify Subjects at Risk for Preterm Delivery". The goal of this study is to identify a non-invasive predictor or predictors that will increase the clinician's ability to identify patients with preterm labor (PTL) at risk for preterm delivery (PTD). Through these studies we also hope to reveal potential therapeutic targets in the prevention of pr...
What is the current status of trial NCT00919412?
This trial is currently terminated. The enrollment target is 32 participants. The study started on 2007-06. Estimated completion is 2010-09.
Who is sponsoring clinical trial NCT00919412?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia